Skip to content

The effect of fire dragon cupping therapy on cancer-related fatigue patients with Yang deficiency during gynecological chemotherapy based on the theory of supporting yang

The effect of fire dragon cupping therapy on cancer-related fatigue patients with Yang deficiency during gynecological chemotherapy based on the theory of supporting yang

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052054
Enrollment
Unknown
Registered
2021-10-15
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related fatigue

Interventions

Experimental group:Fire dragon cupping therapy
Control group:Routine health education

Sponsors

Guangdong Provincial of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients meet the Western medical diagnostic criteria of three major gynecological malignancies (cervical cancer, endometrial cancer and ovarian cancer) and CRF. And patients plan to carry out the second course of chemotherapy TP/TC regimen; 2. TCM syndrome type conforms to Yang deficiency; 3. Piper Fatigue Scale score >= 3, and the estimated survival time is > 6 months; 4. Aged 18 to 60 years; 5. Conscious, without mental illness and cognitive impairment, able to communicate effectively and complete the evaluation scale; 6. The patient or family members voluntarily signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with moderate or above anemia (hemoglobin HB < 90 g/L); 2. Patients with grade II or above bone marrow suppression during chemotherapy (hemoglobin < 80 g/L, leukocyte < 2.0 x 10^9/L, platelet < 50 x 10^9/L, granulocyte < 1.0 x 10^9/L); 3. Pregnant or lactating women; 4. Patients had skin lesions or skin diseases on the back or foot, or patients with severe diabetes, heart, liver and kidney dysfunction and coagulation disorders; 5. Patients who are currently participating or have participated in other clinical trials within 1 month before this study.

Design outcomes

Primary

MeasureTime frame
Piper fatigue survey scale;TCM(Traditional Chinese Medicine) syndrome score table;Quality of life scale;

Secondary

MeasureTime frame
Blood cell examination;

Countries

China

Contacts

Public ContactHe Haixia

Guangdong Provincial of Chinese Medicine

heidy08@163.com+86 13794360392

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026